Therapeutic agents for neurodegenerative diseases
US11793782B2 · kind B2 · utility
1Cited by
1References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 15, 2018 |
| Grant date | Oct 24, 2023 |
| Priority date | — |
| Expiry date | Jun 17, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides for treating neurodegenerative diseases comprising administering leucine, acetyl-leucine or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.